 Home > Medical News > Latest Medical News > Biogen's subcutaneous injection of natalizumab is approved in the EU for the treatment of multiple sclerosis

Biogen's subcutaneous injection of natalizumab is approved in the EU for the treatment of multiple sclerosis

 Last Update: 2021-04-24
 Source: Internet
 Author: User

Tags

endometriosis clinical trials

united rentals new braunfels

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

CompileKe Ke

On April 7, Biogen announced that the European Commission (EC) has approved the subcutaneous injection (SC) agent TYSABRI® (natalizumab, natalizumab) for the treatment of relapsing-remitting multiple sclerosis (MS).

The European Commission’s approval of the route of administration of TYSABRI® SC is based on data from clinical studies DELIVER and REFINE.

Approved by the European Union in 2006, the effectiveness and safety of TYSABRI have been proven through clinical trials and a large amount of real evidence collected in the past 15 years.

TYSABRI increases the risk of progressive multifocal leukoencephalopathy (PML), a rare opportunistic viral infection associated with death or severe disability.

TYSABRI also increases the risk of encephalitis and meningitis caused by herpes simplex and herpes zoster viruses.

Reference source: The European Commission Grants Marketing Authorization for New Subcutaneous Administration of TYSABRI® (natalizumab) to Treat Relapsing-Remitting Multiple Sclerosis

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.